Market Research Blog – Page 3513 – New Product Development

Global Vagus Nerve Stimulator Industry Records Remarkable 10.6% CAGR, According to FMI Insights’ Projections for 2018-2026

In a paradigm-shifting revelation, Future Market Insights (FMI) has conducted a comprehensive intelligence study that brings to light a remarkable surge in the Global Vagus Nerve Stimulator Industry. The study identifies implantable vagus nerve stimulators as the driving force behind substantial revenue growth, with a robust year-on-year increase of more than 9% predicted for 2019.

The industry’s landscape is undergoing a transformative shift, marked by a gradual transition from implantable devices to non/minimally invasive alternatives. This evolution sets the stage for the ascension of transcutaneous Vagus Nerve Stimulators (VNS) in the coming decades. FMI’s insightful study reflects the global medical community’s growing interest in these innovative approaches, signifying a transformative wave poised to reshape the industry.

Of the total global population afflicted by neurological disorders, approximately 50% suffer from an epileptic disorder, according to research and surveys. This statistic underscores the critical importance of advancements in Vagus Nerve Stimulator technology, especially as it directly addresses the needs of a significant portion of the affected population.

Vagus nerve stimulation is witnessing a rapidly expanding applicability beyond epilepsy, in the recent past.
Research uncovers the potential efficiency of vagus nerve stimulation in the obesity management of depression patients.
The positive outcome of vagus nerve stimulation in treatment-resistant depression and epilepsy surgery indicates promising opportunities approaching shortly.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-7759

Europe Steals the Limelight, Crossing US$ 100 Million Revenue in 2019

North America currently holds a massive revenue share in the vagus nerve stimulator market, and FMi projects continued dominance of this region over other regional markets in the coming years. However, the report forecasts the emergence of Europe and Asia Pacific (excluding Japan) as highly attractive territories for key market players shortly. Europe will reportedly cross the US$ 100 million mark in 2019, reflecting the most lucrative opportunities for vagus nerve stimulator manufacturers.

“At present, Europe and APEJ hold a collective revenue share of over 40% in market, of which the former is gradually moving towards extending its individual market value share up to 1/4^th of the global revenue,” explains a senior research analyst at FMI. Adding further, the analyst says, “Favorable regulatory and reimbursement scenario across Europe and relatively easy availability of VNS systems are most prominently driving the growth of vagus nerve stimulator market in Europe. VNS sales in Europe will also benefit from the strong presence of leading industry manufacturers in the region”.

Taxonomical Insights – By Type, Application, and End User

The type of vagus nerve stimulator, implantable stimulator continues to bring in most of the revenue to the market.
Epileptic seizures secure the spot of the most sought-after application type in the vagus nerve stimulator landscape.
Hospitals remain the largest end-users of vagus nerve stimulators. FMI research indicates that specialty clinics and home care settings emerge as attractive end-user candidates in recent years.

Get Expert Advice
https://www.futuremarketinsights.com/ask-question/rep-gb-7759

A thorough competition analysis of the vagus nerve stimulator landscape reveals a few important developmental strategies that are ruling the minds of VNS manufacturers at present.

Besides geographical expansion, leading players in the vagus nerve stimulator market are focusing on the extension of their existing offerings portfolio, according to the report.
To address the challenges to VNS adoption posed by the high price point, companies are now reassessing their pricing strategies for a competitive advantage.
Some companies are also directing their strategic focus on a stronger distribution network.
Strategic partnerships with local and regional distributors and retailers hold immense importance for the competitors in the VNS landscape.
Long-term contractual collaborations with recognized hospitals, research and pathology laboratories, and CROs are emerging as a growing trend among manufacturers of vagus nerve stimulators.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Linerless Label Market to Reach US$ 3.0 Billion by 2033, Driven by Eco-Conscious Consumer Preferences and Reduced Environmental Impact

The global linerless label market is poised for remarkable growth, with a projected value of US$ 1.9 billion in 2023, surging to US$ 3.0 billion by 2033 at a robust Compound Annual Growth Rate (CAGR) of 4.9%. This surge is fueled by a confluence of factors reshaping the packaging landscape and driving industry innovation.

Get a Report Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-1822

Key Market Trends and Highlights:

Environmental Sustainability: Linerless labels are at the forefront of eco-conscious packaging solutions, reducing waste and minimizing environmental impact. As consumer preferences increasingly lean towards sustainability, linerless labels emerge as a preferred choice for businesses committed to responsible consumption.
Cost Efficiency: Manufacturers benefit from reduced material and labor costs associated with linerless labels, bolstering profitability and operational efficiency. The streamlined production processes enabled by linerless labeling systems enhance output and competitiveness in the market.
Versatility Across Industries: Linerless labels find widespread adoption across diverse sectors including food, logistics, and retail, owing to their versatility and adaptability to varying packaging needs.
Integration with Smart Technology: The integration of linerless labels with smart technologies such as RFID and QR codes opens new avenues for product tracking, authentication, and marketing strategies, enhancing consumer engagement and brand visibility.

Key Drivers of the Linerless Label Market:

Stringent Labeling Regulations: Increasing regulatory standards drive demand for linerless labels, ensuring compliance with product safety and consumer protection requirements.
Design Flexibility: Linerless labels offer unparalleled design flexibility, allowing businesses to create visually appealing branding solutions that captivate consumer attention and reinforce brand identity.
Enhanced Product Shelf Life: Linerless labels can incorporate freshness indicators and expiration date extensions, prolonging product shelf life and enhancing consumer confidence in product quality.
Technological Advancements: Improved linerless labeling technology minimizes equipment maintenance and downtime, optimizing production efficiency and ensuring uninterrupted workflow.

Purchase Now to Access Segment-specific Information and uncover Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/1822

Key Trends and Opportunities:

Sustainability Integration: Aligning packaging materials with sustainability trends demonstrates a commitment to eco-friendliness and responsible consumption, resonating with environmentally-conscious consumers.
Product Security and Integrity: Plastic liners safeguard products, ensuring their security and integrity within packaging, thereby bolstering trust and quality assurance among consumers.

Key Takeaways:

The consistent growth of the logistics sector across all geographies, coupled with high requirement of linerless labels for inventory management, asset tracking, and goods distribution, is steadily driving the linerless labels market.

The retail industry is a prominent end user of linerless labels, owing to rising efforts across the world to reduce the incidence of counterfeiting.
North America and APEJ are expected to account for a major portion of the linerless labels market share. Rapid expansion of pharmaceutical and food & beverage industries is boosting the growth of the linerless labels market in these regions.
Digital printing and flexo printing are projected to dominate the global linerless labels market, and hold nearly half of the market share by the end of 2029.

Key Companies Profiled

RR Donnelley & Sons Company
Avery Dennison Corp.
Zebra Technologies Corp.
SATO Holdings Corporation
Coveris
Multi-Color Corporation
CCL Industries Inc.
Yupo Corporation
Ravenwood Packaging
General Data Company Inc.
Hub Labels

Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1822

Segmentation Analysis:

By Product Type:

Variable Imaged
Direct Thermal

By Printing Technology:

Digital Printing
Flexo Printing
Offset Printing
Gravure Printing
Screen Printing
Others

By Adhesion:

Permanent
Removable
Repositionable

By End User:

Retail
Food & Beverages
Logistics
Pharmaceuticals
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa

Author

Ismail Sutaria (Lead Consultant, Packaging and Materials) has over 8 years of experience in market research and consulting in the packaging & materials industry. Ismail’s strength lies in identifying key challenges faced by the client and offering logical and actionable insights to equip the clients with strategic decision-making power.

Ismail has been an instrumental part of several transformational consulting assignments. His key skills include competitive benchmarking, opportunity assessment, macroeconomic analysis, and business transformation advisory. Ismail is an MBA holder in Marketing and has a Bachelor’s Degree in Mathematics.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Recombinant Vaccines Industry Poised for 6.1% CAGR Victory by 2028 | According to Latest FMI Research

In a groundbreaking revelation, the Global Recombinant Vaccines Industry is gearing up for unprecedented growth, with mature regional markets in North America and Europe emerging as leaders. The stellar performance in these regions can be attributed to the effective presence of leading biopharmaceutical companies equipped with GMP-certified sterile manufacturing facilities. This presence not only ensures product quality but also contributes significantly to the industry’s revenue surge.

Recombinant vaccines, recognized for their inherent safety and cost-effectiveness, are now at the forefront of the global healthcare landscape. The increasing emphasis on preventive healthcare has led to a surge in demand for vaccines worldwide, creating a ripple effect that extends even to developing economies. However, a significant challenge arises from the demand-supply gap prevalent in these regions, resulting in limited vaccine availability.

A new Future Market Insights report on the global recombinant vaccines landscape emphasizes the positive revenue growth potential in developing regional markets such as Asia Pacific and Japan. The FMI report also provides a comprehensive analysis of the current competitive landscape, emphasizing exclusive insights gleaned from extensive primary and secondary market research.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-7757

Key Dynamics Analysis Evaluates the Role of Collaborative Activities and R&D

In light of Sanofi’s 2017 acquisition of Protein Sciences, which increased the former’s Flubok (recombinant vaccines for flu) manufacturing capacity, several players in the recombinant vaccines space are planning mutual alliances in the coming years. Strategic collaborations between market leaders in recombinant vaccines are expected to provide a significant boost to overall market growth.

Furthermore, the growing prevalence of rare disease cases such as Ebola, Crimean Congo, MERS, hemorrhagic fever, Marburg, Lassa Fever, Nipah, SARS coronavirus diseases, and Rift Valley Fever, according to WHO, is attracting R&D interests of recombinant vaccine manufacturers, thereby driving market growth shortly.

FMI Study Positions Western Europe as Growth Engine of Recombinant Vaccines Landscape

Western Europe now accounts for just under one-third of global market revenue, owing to increased government support for vaccine development and vaccination campaigns. The presence of key market players in this region, as well as their increasing investments in recombinant vaccine R&D, accentuate Western Europe’s top performance.

The report forecasts strong growth in Asia Pacific and Japan in the coming years. However, APAC is portrayed as particularly profitable due to rapidly increasing healthcare spending and an expanding target population with significant unmet clinical needs, despite rising consumer awareness of the benefits of vaccination.

Exploring the study’s key assumptions. Ask an Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-7757

Segmental Analysis Reveals Neck-on-Neck Competition between Subunit and Attenuated Vaccine Types

Based on the Global Recombinant Vaccines Industry assessment by type, subunit recombinant vaccines currently hold the largest value share but are likely to lose a bit of it to attenuated recombinant vaccines. Both segments collectively cover around 90% share of the total market revenue.
Applications of recombinant vaccines in human vaccination continue to reflect maximum attractiveness over veterinary applications. A majority of the total market revenue is contributed by recombinant vaccines for humans, as indicated by the report.
Private clinics and dispensaries remain the most preferred channel for vaccine distribution, followed by pharmacies. Hospital pharmacies hold a larger share than retail pharmacies, though the latter is poised for promising expansion in coming years.

Top Two Players Represent a Whopping 80% Market Value Share, Concludes Competition Analysis

According to the FMI study, GlaxoSmithKline plc and Merck & Co., Inc. collectively account for more than 80% of revenue share in the recombinant vaccines marketplace, keeping the landscape highly consolidated. While the former primarily focuses on strategic collaborations, the latter strategizes new product launches for an expanded market share.

GSK’s candidate vaccine launched in 2017 claims to prevent pulmonary TB in HIV-negative adult patients.
Merck announced the three studies of the first phase of its investigational pneumococcal vaccine, early in 2018.

Competition tracking uncovers a few more important insights that can potentially direct strategy-building efforts of competitors in the Global Recombinant vaccine industry at a global level.

New market entry aspirants are prominently opting for the adoption of mammalian protein expression systems in recombinant vaccine manufacturing that accelerate the entire production process.
Established players in the recombinant vaccines landscape are prioritizing the development of new variants of existing vaccines.
Contractual alliances with non-profit organizations are likely to earn higher profit shares for manufacturing leaders in the Global Recombinant Vaccines Industry.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-7757

Segmentation

The report on the Global Recombinant Vaccines Industry provides salient information on market players. The Global Recombinant Vaccines Industry is segmented by region, product type, application, and distribution channel, to analyze segment-wise growth of the Global Recombinant Vaccines Industry. Based on regions, the Global Recombinant Vaccines Industry is segmented into seven regions – North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

The Global Recombinant Vaccines Industry by product type is segmented into subunit recombinant vaccines, attenuated recombinant vaccines, and vector recombinant vaccines. By application, the Global Recombinant Vaccines Industry is segregated into human, and veterinary recombinant vaccines. By distribution channel, the Global Recombinant Vaccines Industry is segregated into hospitals, private clinics & dispensaries, retail pharmacies & others.

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Appendage Management Industry Forecasted to Achieve US$352.5 Million Valuation by 2028, Propelling at 6.6% CAGR

The Global Appendage Management Industry is gearing up for a transformative growth phase, as unveiled in the latest comprehensive market analysis by Future Market Insights Inc. This industry is poised to surge from its 2021 valuation of US$ 223.9 Million to an impressive US$ 352.5 Million by the close of 2028, reflecting a robust Compound Annual Growth Rate (CAGR) of 6.6% over the forecast period.

A primary catalyst behind this upward trajectory is the escalating prevalence of atrial fibrillation, identified as one of the most intricate cardiovascular conditions. As life expectancy increases, the incidence of atrial fibrillation follows suit, presenting a complex challenge to healthcare systems worldwide.

According to a senior healthcare analyst at Future Market Insights, “The high mortality and morbidity rates associated with atrial fibrillation, coupled with the occurrence of embolic events such as strokes, significantly contribute to the appendage management landscape. We project a substantial year-on-year growth rate of 6.3% through 2019, with an estimated valuation of approximately US$ 196.2 Million for the same period.”

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-7752

Key Insights on Competitive Landscape Analysis of Global Appendage Management Industry

As per the FMI analysis, given the high revenue contribution by the top five players—including Boston Scientific Corporation, AtriCure, Inc., Abbott Laboratories, Cardia, Inc., and Medtronic plc—holding an accumulative revenue share of nearly 89 percent, the Global Appendage Management Industry showcases a highly consolidated landscape. FMI’s research also indicates that smaller players contribute approximately 11.5 percent of revenue share to the Global Appendage Management Industry. A much more careful competitive landscape analysis of the Global Appendage Management Industry reveals a 3-tier segmentation—depending upon the growth stage of various companies.

With a reach wide enough in North America, Boston Scientific Corporation and AtriCure, Inc. are the clear market leaders—for endocardial and epicardial left atrial closure devices, respectively. With an accumulative share of approximately 57 percent in the appendage management market, Boston Scientific Corporation’s WATCHMAN and AtriCure, Inc.’s products are in direct competition. However, WATCHMAN is the most widely implanted and trusted—boasting FDA approval and CE Mark
Mid-stage growth companies including Abbott Laboratories and Cardia, Inc have pulled away from the top two players, in the last few years—holding approximately 32 percent market share. These companies, however, have an expansive range of product offerings. Holding nearly 14 percent in terms of revenue, Abbott Laboratories is upping its portfolio of upper and lower extremities along with the popularization of the product with good clinical trial results.
The emerging players, including SentreHEART, Inc., LifeTech Scientific Co., Ltd, Occlutech International AB, and Johnson & Johnson Services, Inc. are more focused on product innovation and differentiation within certain treatment niches, to build a strong market position in the consolidated appendage management landscape. Despite a miniscule market share, FMI foresees notable potential for its research and development initiatives in the long run.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-7752

In terms of overall forward market strategies, key companies are projected to focus on innovating easily implantable, life-saving products for patients suffering from atrial fibrillation, thereby, eliminating the side-effects caused by drugs taken to treat atrial fibrillation. Innovative devices and better navigation and visualization technologies are expected to bring significant opportunities—translating into increased adoption of Left Atrial Appendage (LAA) closure devices by catheterization laboratories and hospitals.

Moreover, mergers and acquisitions will remain a key expansion strategy among players in the appendage management market. FMI indicates that acquisitions in the Global Appendage Management Industry would prove beneficial for the key leaders considering the increasing number of promising ongoing or successful researches by emerging companies. Already in a dominant position, key players are increasingly focusing on strengthening the supply chain and distribution networks through strategic partnerships to maximize their market share.

Bonus: Key Market Influencers

Notable success rate of appendage management procedures.
Non-surgical, minimal invasion approach helps in fast recovery and reduces surgical and implantation complications.
Drawback of oral anticoagulant drugs to push the demand for appendage management procedures.

Global Appendage Management Industry by Category By Product Type

Epicardial LAA Closure Devices
Endocardial LAA Closure Device

By End User

Hospitals
Cath Labs

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/7752

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Temperature-Controlled Pharmaceutical Containers Market to Reach US$ 11.2 Billion by 2032, Fueled by Rising Demand for Product Safety in Healthcare

The global temperature-controlled pharmaceutical containers market is poised for exponential growth, with a projected valuation of US$ 4.9 billion in 2022, surging at a remarkable Compound Annual Growth Rate (CAGR) of 8.5% to reach US$ 11.2 billion by 2032. As per industry analysis, the top 3 countries are anticipated to capture 35-40% of the market share by the end of 2022, underscoring the sector’s burgeoning significance in healthcare logistics.

Driving Forces Behind Market Expansion:

The burgeoning demand for product safety, particularly within the healthcare industry, drives the unprecedented growth of the temperature-controlled pharmaceutical containers market. These containers serve as indispensable tools in preserving the efficacy and integrity of medical supplies, ensuring the safe transportation of critical drugs and vaccines across the globe.

Experience the Insights Firsthand: Request a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6390

Combatting Medication Waste through Innovation:

With a steadfast focus on upholding the integrity of life-saving drugs and vaccines, temperature-controlled solutions emerge as pivotal assets in mitigating medication waste. Cold chain packaging solutions play a pivotal role in safeguarding blood, vaccines, and other essential medical supplies, addressing the rising demand among patients and the prevalence of routine diseases.

The Remunerative U.S. Market Landscape:

The United States emerges as a lucrative hub for temperature-controlled pharmaceutical containers, propelled by the nation’s robust pharmaceutical market. As per projections by the International Federation of Pharmaceutical Manufacturers & Associations, total spending on medicines in the U.S. is slated to reach a staggering US$ 625 billion by 2023, solidifying its position as the largest and most developed pharmaceutical market globally.

Moreover, with the presence of the world’s leading pharmaceutical companies, the U.S. stands as a beacon of innovation and opportunity within the temperature-controlled pharmaceutical containers market, offering a fertile ground for expansion and strategic investments.

Embracing Innovation for Healthcare Logistics:

As the temperature-controlled pharmaceutical containers market continues to evolve, industry stakeholders are poised to leverage innovation and technological advancements to optimize healthcare logistics. From extending shelf life to safeguarding critical medical supplies during transit, temperature-controlled solutions play an indispensable role in enhancing patient outcomes and ensuring supply chain efficiency.

Purchase Now to Access Segment-specific Information and uncover Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/6390

Business Growth Opportunities:

Global Expansion: Explore opportunities to expand into emerging markets where the demand for temperature-controlled pharmaceutical containers is growing due to increased healthcare infrastructure and pharmaceutical manufacturing.
Technological Innovation: Invest in research and development to enhance container technologies, such as the development of smart containers with real-time temperature monitoring and tracking capabilities, to meet the evolving needs of the pharmaceutical industry.
Strategic Partnerships: Form strategic partnerships with pharmaceutical manufacturers, logistics companies, and regulatory bodies to create a seamless and compliant supply chain for temperature-sensitive pharmaceuticals.
Customization and Personalization: Offer customized solutions to pharmaceutical companies, allowing them to tailor temperature-controlled containers to specific product requirements, ensuring the highest level of efficacy and compliance.
Environmental Sustainability: Embrace environmentally friendly practices by developing containers that are not only temperature-controlled but also sustainable, meeting the increasing demand for eco-friendly solutions in the pharmaceutical industry.

Trends in the Temperature Controlled Pharmaceutical Containers Industry:

Increasing Stringency in Regulatory Standards: The market is witnessing a trend of stricter regulatory standards for the transportation and storage of pharmaceuticals, driving the demand for advanced temperature-controlled containers that ensure compliance with these standards.
Rise of Biopharmaceuticals: The growing prevalence of biopharmaceuticals, which are often more sensitive to temperature variations, is fueling the need for specialized temperature-controlled containers that can maintain the integrity of these complex drugs during transportation and storage.
Integration of IoT and Data Analytics: The incorporation of Internet of Things (IoT) technologies and data analytics in temperature-controlled containers is on the rise. This allows real-time monitoring of temperature conditions, ensuring better control and visibility throughout the supply chain.
Focus on Cold Chain Logistics: With the increasing importance of maintaining a seamless cold chain, there is a trend towards integrating temperature-controlled containers with advanced cold chain logistics solutions to ensure the safe and efficient transport of pharmaceutical products.
Shift towards Single-Use Containers: There is a noticeable shift towards the adoption of single-use temperature-controlled containers, driven by their cost-effectiveness, reduced risk of contamination, and the ability to eliminate the need for return logistics, making them a more attractive option for certain pharmaceutical products.

Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6390

Temperature Controlled Pharmaceutical Containers Industry by Category

By Control Type:

Active
Passive

By Form:

Chest Style
Upright Style

By Application:

Frozen
Chilled
Ambient

By Content Type:

Vaccines/Drugs (IV)
Samples (Blood, Biopsy, Etc.)
Reagents
Genetic Materials

Author

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Endoscopy Fluid Management Systems Industry to Achieve US$ 683 Million by 2028, Marking a 7.4% Compound Annual Growth Rate

The latest study by Future Market Insights (FMI) reveals an unwavering trajectory for the Global Endoscopy Fluid Management Systems Industry. With Tier 1 players firmly holding over 70% of the market revenue, the industry landscape remains highly consolidated, showcasing the dominance of key market players.

In 2021, the Global Endoscopy Fluid Management Systems Industry showcased a robust valuation of US$ 414 Million. FMI’s projections indicate a significant leap at an impressive 7.4% Compound Annual Growth Rate (CAGR), reaching a remarkable US$ 683 Million by 2028. This growth trajectory underscores a promising future for the industry, highlighting its resilience and adaptability in the dynamic healthcare market.

A pivotal aspect of FMI’s study is the comprehensive overview of FDA regulations governing Class II medical devices, with a specific focus on endoscopes. The report delves into the intricacies of these regulations, offering valuable insights for industry stakeholders and decision-makers.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4358

Top 3 Insights from Key Players Analysis

While a majority of companies are focusing on new product launches, strategic mergers and acquisitions are likely to emerge as the most profitable developmental decisions shortly. Most of these strategic moves will be primarily directed to address the high price point pressure associated with endoscopy fluid management systems that often affect revenue growth in developing economies.

“Major hospital networks in developed regional markets are witnessing M&A between hospitals, which is likely to shape costing of medical devices such as endoscopy fluid management systems – eventually slashing down the profitability margins of manufacturers. “Constantly increasing chronic disease instances, coupled with immense technological advances in the field of endoscopy, is prominently driving the US$ 342 Million market for endoscopy fluid management systems (or irrigation pumps) in recent years,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Prominent Players:

Karl Storz GmbH & Co KG
Olympus Corporation
Richard Wolf GmbH
Smith & Nephew
Stryker Corporation
DePuy Synthes (Johnson & Johnson Services Inc.)
Cantel Medical Corporation
Medtronics Plc.
B. Braun Medical Inc.
Hologic Inc

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-4358

Top 5 Insights from Segmental Analysis

With maximum use in laparoscopic procedures, endoscopy fluid management systems continue to register maximum revenue generation through sales of laparoscopy suction irrigation pumps, followed by laparoscopy fluid management systems.

Based on the modality of endoscopy fluid management systems, the Benchtop holds a substantial market value share.

Hospitals register the highest consumption of endoscopy fluid management systems.

Owing to a massive number of cancer survivors in the US, North America’s market for endoscopy fluid management systems is currently accounting for the largest revenue share in the global landscape, followed by Asia Pacific and Europe.

MEA and Latin America are likely to represent a significant incremental opportunity, according to an FMI study.

Healthy Year-over-Year Revenue Growth Projected for Asia Pacific

APAC has become the hotspot for leading medical device companies, which is further intensified by the dramatically growing medical tourism sector. Across APAC, Japan is likely to account for substantial revenue generation, enabling the regional market to secure a second spot in the global endoscopy fluid management systems landscape. FMI projects over 7% year-on-year revenue growth in 2020 and beyond, for this regional market.

Government Regulations Favor Market Growth in Latin America

The Latin American market for endoscopy fluid management systems is thriving at a promising pace owing to favorable government initiatives regarding endoscopic procedures and medical device marketing. Noteworthy demand for laparoscopy suction irrigation pumps within the region is identified to be responsible for the rapid revenue growth of the endoscopy fluid management systems marketplace across Latin America.

Egypt’s End Users Drive Market Growth in MEA

The market for endoscopy fluid management systems in MEA is prominently driven by the improving regulatory landscape related to the marketing of medical devices, pushed further by impressive sales of laparoscopy suction irrigation pump-based endoscopy fluid management systems. FMI spots higher market attractiveness in Egypt owing to the presence of a large number of end users. However, a poor operational environment still remains a major growth barrier for the region.

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/4358

Key Segments Covered in Global Endoscopy Fluid Management Systems Industry Survey

Global Endoscopy Fluid Management Systems Industry by Product Type:

Laparoscopy endoscopy fluid management systems
Hysteroscopy endoscopy fluid management systems

Global Endoscopy Fluid Management Systems Industry by Modality:

Floor Standing endoscopy fluid management systems
Benchtop fluid management systems

Global Endoscopy Fluid Management Systems Industry by End-User:

Hospital endoscopy fluid management systems
Ambulatory Surgical Centers’ endoscopy fluid management systems
Specialty clinic’s endoscopy fluid management systems
Diagnostic center’s endoscopy fluid management systems

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Vein Finder Industry Showcases Impressive 10.9% CAGR, Targets US$ 86.8 Million Valuation by 2028 | FMI Reveals

The Global Vein Finder Industry, which reached a significant valuation of approximately US$ 46.7 million in 2022, is on the verge of a groundbreaking surge, anticipating a market valuation of US$ 86.8 million by the year 2028. The industry’s unprecedented growth trajectory is underscored by a robust Compound Annual Growth Rate (CAGR) of 10.9%, as revealed in the latest analysis by FMI.

The driving force behind this remarkable ascent is the infusion of cutting-edge Vein Finder technology within the medical device sector. These innovative devices harness state-of-the-art technologies, providing substantial advantages to healthcare professionals, including physicians, nurses, and phlebotomists.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-7640

“Innovations like these are expected to increase adoption of advanced Vein Finders in hospitals and healthcare establishments, leading to significant revenue growth of the Global Vein Finder Industry. Our analysis of the performance of the Vein Finder market reveals an absolute $ opportunity of US$ 3.0 Million between 2018 and 2019 and the global market is estimated to register a stellar growth rate of 10.9% in the coming decade.” Practice Head – Healthcare & Medical Devices, Future Market Insights

Global Vein Finder Industry Structure Overview: Regional Focus to Bolster Global Market Growth

An overview of the market structure of the Global Vein Finder Industry reveals a strong regional presence of top market companies as well as local players. Leading companies operating in the Global Vein Finder Industry are leveraging acquisitions as a primary strategy to facilitate regional market expansion. Future Market Insights analysis also observes a strong focus by Vein Finder companies on R&D for new product development and expansion of the existing product line in key regional growth markets.

“Implementation of inorganic growth strategies is seen as the way forward to penetrate key growth markets across certain developing regions. Companies in the Vein Finder market with diversified product offerings are collaborating with local regional players to introduce low-cost Vein Finder products to cement their presence across top regional markets.”

In 2017, the leading three companies in the Global Vein Finder Industry held a revenue share of about 56% while the remaining players contributed about 44% market share. New product development is a key strategy adopted by players in the Global Vein Finder Industry to increase their brand value. Rising difficulties associated with peripheral venous access, venepuncture is one of the primary factors boosting the growth of the Global Vein Finder Industry, and key players are capitalizing on the growth drivers to increase their market share.

Ask an Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-7640

Future Market Insights predicts lucrative revenue growth in the various regional markets of Europe and Asia Pacific Excluding Japan. Europe will likely remain the top market for sales of Vein Finder devices owing to the increasing adoption of Vein Finder across hospitals and clinics to locate veins for drawing blood samples, IV insertions, and other vascular procedures.

Portable Vein Finder to Garner Maximum End User Demand; Infrared Technology to Register Fastest Growth in Revenue

Portable Vein Finders are likely to be the most preferred product type in the Global Vein Finder Industry, registering impressive demand as well as sales growth in the coming decade. The convenience and ease of use offered by portable Vein Finders is the primary factor boosting adoption across hospitals, clinics, and other healthcare institutions. The Global Vein Finder Industry is fuelled by advanced technology with infrared technology being the most adopted in Vein Finders. Among the various end users of Vein Finders, hospitals are likely to exhibit the highest demand in the next 10 years, also contributing to maximum revenues in the Global Vein Finder Industry.

Competitive Landscape

The market for Vein Finders is fragmented by nature, with only a few players present. These players are part of several strategic alliances. The product launch and acquisition speed up the manufacturer’s strategy to capitalize on market share and gain a sizable market share.

Furthermore, the corporations are focusing on the launch of new items to boost their product portfolio in the Asia Pacific area to expand their clientele and capture the largest market share in emerging economies.

Global Vein Finder Industry Key Players

AccuVein Inc.
Christie Medical Holdings
Koninklijke Philips N.V
Osang Healthcare Co. Ltd
Teleflex Inc. (Acq. VueTek Scientific, LLC.)
TransLite, LLC
ZD Medical
Vivolight
Venoscope LLC
Shenzhen Bestman Instruments Co., Ltd

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/7640

Global Vein Finder Industry by Category

By Product:

Portable
Benchtop

By Technology:

Ultraviolet
Infrared
Ultrasound

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Centers and Path Labs
Veterinary Clinics
Home Care Settings
Blood Banks

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Evolving Trends in Metal Cans: Innovations in Design and Material Counter the Rise of Bio-Based Plastics, Forecasted 2% CAGR by 2034

The metal can market is poised for substantial growth, fueled by a confluence of factors including heightened environmental awareness, evolving consumer preferences, and expanding applications across various industries. With a projected CAGR of 2%, the market is set to burgeon from US$ 40.4 billion in 2024 to US$ 49.3 billion by 2034.

Notably, aluminum is anticipated to emerge as a favored material for can production, driven by its recyclability and eco-friendliness. Increasing demand for ready-to-eat foods and beverages globally, particularly in developing regions, further propels the adoption of metal cans across diverse sectors.

Moreover, heightened consumer awareness regarding the safety and health aspects of packaging materials is driving the preference for non-carcinogenic elements, bolstering the sales of metal cans. The future trajectory of the metal can industry hinges on sustained investments in innovation and sustainability initiatives, paving the way for ecologically sound packaging solutions that align with evolving consumer demands.

Request For a Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-6372

Growth Drivers of the Metal Cans Industry:

Preservation of Food Products: Metal cans emerge as a preferred solution for preserving food items, especially in light of reduced availability of fresh produce, offering extended storage and maintenance of product quality.
Expansion of Supermarkets and Convenience Stores: The proliferation of supermarkets and modern convenience stores globally provides a significant impetus to market growth, bolstering accessibility and consumer reach.
Demand for Sustainable Packaging Solutions: Increasing consumer preference for low-priced and sustainable packaging options like steel and tin cans drives market expansion, aligning with environmentally-conscious consumer trends.
Consumer Awareness on Packaging Constituents: Heightened consumer awareness regarding the use of non-carcinogenic constituents in packaging further supports market growth, emphasizing the importance of safe and sustainable packaging materials.

Challenges and Innovations:

Rise of Bio-Based Plastic: The adoption of bio-based plastic in food and beverage packaging presents a challenge to metal can manufacturers, as key players explore cost-efficient and sustainable alternatives, potentially limiting future demand for metal cans.
Emphasis on Modified Designs: Metal can manufacturers are innovating with modified designs to enhance quality and captivate consumer attention. Techniques such as thermochromic and photochromic inks, along with digital printing, offer engaging visuals and interactive features, driving consumer engagement and product sales.

Robust Demand in the Food Industry:

Metal cans continue to witness robust demand in the food industry, fueled by the growth of organized retail. Canned food and beverages offer prolonged shelf life and preservation of nutritional value, making them a favored choice among consumers and retailers alike.

As the metal cans market evolves, manufacturers remain committed to delivering innovative solutions that meet the evolving needs of consumers and industries worldwide.

Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6372

Business Trends:

Customized Packaging Solutions: The market sees a trend towards offering customizable metal can designs, catering to brand identity and consumer preferences for unique and personalized packaging.
Increasing Adoption of Hybrid Packaging: Companies explore hybrid packaging solutions, combining metal cans with other materials, to create innovative and functional packaging designs with enhanced features.
E-commerce Packaging Surge: The rise of e-commerce leads to a surge in demand for durable and protective packaging, driving the adoption of metal cans as a reliable and secure option for shipping various products.
Premiumization of Packaging: Premium and luxury brands are increasingly opting for metal cans, leveraging the material’s sleek and premium appearance to enhance product positioning and attract discerning consumers.
Smart Packaging Integration: The incorporation of smart packaging technologies, such as QR codes and NFC tags, into metal cans allows brands to engage consumers, provide information, and track product authenticity, contributing to market trends

Key Companies Profiled

Rexam PLC
Silgan Containers LLC
Kian Joo Can Factory Berhad
Independent Can Company
Trinity Holdings
Berlin Packaging Company
Crown Holdings, Inc.
SKS Bottle & Packaging, Inc.
Caira Can Company Limited
Toyo Seikan Co LTD

Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6372

Metal Cans Market: Segmentation

Material Type:

Aluminum
Steel
Tin

Fabrication Type:

Two Piece Can
Three Piece Can

Application:

Alcoholic Beverages
Non-Alcoholic Beverages (Aerated and Non-Aerated Beverages)
Processed Dairy Food Products
Other Processed Food Products
Edible Oil
Medicinal Tablets and Syrups
Personal Care and Cosmetic Products
Industrial Chemicals

End User:

Food & Beverages
Pharmaceutical Industry
Consumers Goods
Chemical

Region:

North America
Latin America
Europe
Japan
Asia Pacific excluding Japan(APEJ)
Middle East and Africa (MEA)

Author

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Narcolepsy Treatment Industry Set for a Whopping US$6.67 Billion Valuation by 2028, Fueled by 5.7% CAGR

The Global Narcolepsy Treatment Industry is on the verge of a remarkable upswing, with projections painting a robust growth trajectory. According to Future Market Insights (FMI), the sector is anticipated to surge from an estimated US$4.77 billion in 2022 to an impressive US$6.67 billion by 2028, reflecting a noteworthy Compound Annual Growth Rate (CAGR) of 5.7% over the forecast period (2022-2028).

FMI’s recent market intelligence overview highlights a substantial demand for narcolepsy treatment, particularly in North America. The region is experiencing a rising preference for prescription medicines, coupled with a significant adherence to long-term treatment plans. This prevailing trend is poised to catalyze substantial revenue growth in the narcolepsy treatment landscape across Europe as well.

The burgeoning market is underpinned by advancements in the neurobiology of sleep over the past few decades. Notably, the proliferation of animal models for investigating the neurological functions of the brain has played a pivotal role in understanding potential complexities and the brain’s role in sleep.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-7641

Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:

Strong distribution pipeline of narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
The prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
The prevalence of sleep apnea is more severe in developing countries due to the lack of skilled physicians

In terms of key forward market strategies, the primary objective of manufacturers in the Global Narcolepsy Treatment Industry is to expand their footprint in the various regional markets, to solidify their market position.

Key Findings from the Regional and Competitive Landscape Analysis of the Global Narcolepsy Treatment Industry

Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low-cost generic versions of patented drugs, strategic partnerships and acquisitions with pave the way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused on introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospitals and retail, drug stores, and e-commerce. Sales through an e-commerce distribution channel are expected to contribute a significant revenue share in the Global Narcolepsy Treatment Industry.
FMI has also noted an increasing focus on the reformulation of well-known products and combinations, by manufacturers in North America to achieve higher sales and wide penetration

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-7641

There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs. Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids.

Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home-based unit, further reducing the dependency on OTC pills and prescription drugs.

While explaining the growth trajectory of the Global Narcolepsy Treatment Industry, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand for narcolepsy treatment through 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations, and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.

Critical Market Restrainers

Although the narcolepsy market is expanding at a robust CAGR, long waiting times for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aid medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of Global Narcolepsy Treatment Industry.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-7641

Key Market Segments Covered in Global Narcolepsy Treatment Industry Research

By Product:

Narcolepsy Treatment Drugs
- Modafinil
- Sodium Oxybate
- Armodafinil
- Others
Devices
- CPAP Devices
- BiPAP Devices
- APAP Devices

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
e-commerce
Drug Stores
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Sustained Release Excipients Industry Poised for Unprecedented 6.8% CAGR Surge through 2026 | Predicts FMI

The Global Sustained Release Excipients Industry is on the brink of an unprecedented era of expansion, poised for a remarkable Compound Annual Growth Rate (CAGR) of 6.8% that is expected to reshape market dynamics through 2026. This projected growth signals a pivotal departure from historical trends characterized by regional competition and pricing strategies.

Traditionally, the industry landscape has been shaped by intense rivalry among regional manufacturers, each vying for supremacy through competitive pricing. This approach, however, led to a fragmented market and impacted overall profitability. In a noteworthy shift, the Global Sustained Release Excipients Industry is now undergoing a transformative phase.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-7580

Companies like BASF Corporation, Ashland Global Holdings Inc., and Dow Chemical Company generate more than 42.8% of the market’s revenue for sustained release excipients globally. The businesses involved in this industry are collaborating with local distributors to increase the penetration of their products in the Global Sustained Release Excipients Industry.

Research identifies the largest revenue shareholding categories in the sustained release excipients marketplace based on product type, end-user, and route of administration.

Polymer is currently the largest product type category worth US$ 300 Million, whereas gelatin represents the most opportunistic one.
While the oral route of administration remains highly sought after, injectable is presumed to gradually take over.
Biopharmaceutical companies and CMOs pose fierce competition to pharmaceutical companies – the dominant end-user of sustained-release excipients.

“The top five players leading the competition in the global sustained release excipients landscape account for a collective revenue share of over 50%, whereas several relatively small companies represent the rest. A majority of competitors have a limited offering portfolio and significantly depend on product differentiation for an edge in niche treatment areas,” explains a senior research analyst. “Product innovation and market expansion have been the top developmental strategies of companies so far, which are now complemented with strategic partnerships,” the analyst adds further.

Ask from Market Research Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-7580

Multi-level Partnerships – The Key to Delivering Top-Notch Excipient Formulations

FMI underlines the critical role of strategic collaborations – between formulators of sustained release excipients and stakeholders across the value chain – in shaping the growth of brands as well as the entire sustained release excipients ecosystem.

While partnerships are expected to prominently focus on spotting the key challenges facing manufacturers, continued education about functionality, variability, and consistency of sustained release excipients is also an important objective. Drug product manufacturers working in tandem with formulators of sustained-release excipients are helping companies deliver best-in-class solutions addressing the most prominent pull factors associated with sustained-release excipients.

To best grasp real-time market needs, sustained-release excipient formulators are most likely to strengthen interaction with end-user customers. This move offers a dual advantage as a developmental strategy – by helping manufacturers precisely understand and address the challenges facing pharmaceutical markets and stimulating the development of new excipient formulations that tap into evolving needs.

A recent deal (2017) involving the combination of The Dow Chemical Company-DuPont-FMC (Health & Nutrition) has been a classic example of a collaborative operation, involving channel partners as well as customers.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-7580

Additional Questions Answered

Some of the additional questions addressed in this report on the Global Sustained Release Excipients Industry-

What is the revenue potential of the sustained release excipients market across regions of North America and Europe?
Who are the key competitors and what are their portfolios in the sustained release excipients market?
What are the major challenges influencing the growth of the sustained-release excipients market?
How intervention from regulatory authority is shaping the sustained release excipients market growth?

Competitive Landscape:

The competition section of the Global Sustained Release Excipients Industry features profiles of key players operating in the industry based on their market shares, differential strategies, product offerings, marketing approach, and company dashboards. Examples of some of the key players featured in this report include FMC Corporation, Ashland Global Holdings, BASF Corporation, The Dow Chemical Company, Roquette Freres S.A. Colorcon Inc., and Croda International Inc.

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/7580

Global Sustained Release Excipients Industry Segmentation:

The report offers a comprehensive taxonomy of the Global Sustained Release Excipients Industry based on product type, end-user, route of administration route, and region. The sustained-release excipients are sold for various types of test samples, such as blood, skin, etc. These sustained-release excipients are used by pharmaceutical companies, biopharmaceutical companies, and neutraceutical companies, and for various types of sustained-release excipients, such as food allergies, drug allergies, latex allergies, and other types of allergies.

End-use segments in the Global Sustained Release Excipients Industry which are a part of this sustained release excipients market report include pharmaceutical companies, biopharmaceutical companies, and other end users, such as nutraceutical manufacturers and contract manufacturing organizations. The sustained release excipients market has been analyzed across regions of North America, Latin America, Europe, CIS & Russia, Asia Pacific, and MEA.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani